Fauci Receives Funding For New Marburg Vaccines For You October 23, 2021
The Washington, DC-based Sabin Vaccine Institute announced on October 21, 2021, the Biomedical Advanced Research and Development Authority (BARDA) had exercised the third contract option, valued at $34.5 million, to advance the development of vaccines against Ebola Sudan and Marburg viruses.
This third contract option will enable continued nonclinical efficacy and safety studies, Phase 2 clinical trials in Africa, and vaccine manufacturing processes to ensure quality and safety.
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…